Renal nerve ablation: Emerging role in therapeutics

References

• DiBona GF. Physiology in perspective: The wisdom of the body. Neural control of the kidney. Am J Physiol Regul Integr Comp Physiol. 2005;289:R633–R641.
   PubMed Web of Science ®Google Scholar
• Schlaich M, Sobotka P, Krum H, Whitbourn R, Walton A, Esler MD. Renal denervation as a therapeutic approach for hypertension: Novel implications for an old concept. Hypertension. 2009;54:1195–1201.
   PubMed Web of Science ®Google Scholar
• Campese VM, Kogosov E. Renal afferent denervation prevents hypertension in rats with chronic renal failure. Hypertension. 1995;25:878–882.
   PubMed Web of Science ®Google Scholar
• Winternitz SR, Katholi RE, Oparil S. Role of the renal sympathetic nerves in the development and maintenance of hypertension in the spontaneously hypertensive rat. J Clin Invest. 1980;66:971–978.
   PubMed Web of Science ®Google Scholar
• DiBona GF, Kopp UC. Neural control of renal function. Physiol Rev. 1997;77:75–197.
   PubMed Web of Science ®Google Scholar
• Allen EV and Adson AE. The treatment of hypertension: Medical versus surgical. Ann Int Med. 1940;14:288–307.
   Google Scholar
• Peet MM. Hypertension and its surgical treatment by bilateral supradiaphragmatic splanchnicectomy. Am J Surg. 1948; 75:48–68.
   Google Scholar
• Smithwick RH. Surgery of the autonomic nervous system. N Engl J Med. 1947;236:662–669.
   Google Scholar
• Smithwick RH, Thompson JE. Splanchnicectomy for essential hypertension; results in 1,266 cases. JAMA. 1953;152: 1501–1504.
   PubMed Web of Science ®Google Scholar
• Oparil S. Can catheter-based renal denervation be used safely and effectively to substantially reduce blood pressure in treatment-resistant hypertensive patients. Curr Cardiol Rep. 2011; in press.
   Google Scholar
• Krum H, Schlaich M, Whitbourn R, Sobotka PA, Bartus K, Kapelak B, . Catheter-based renal sympathetic denervation for resistant hypertension: A multicentre safety and proof-of-principle cohort study. Lancet. 2009;373:1275–1281.
   PubMed Web of Science ®Google Scholar
• Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med. 2009;361:932–934.
   PubMed Web of Science ®Google Scholar
• Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M, Symplicity HTN-2 Investigators. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): A randomised controlled trial. Lancet. 2010;376:1903–1909.
   PubMed Web of Science ®Google Scholar
• Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension: Durability of blood pressure reduction out to 24 months. Hypertension. 2011;57:911–917.
   PubMed Web of Science ®Google Scholar
• Alexander CJ, Tangchitnob EP, Lepor NE. Polycystic ovary syndrome: A major unrecognized cardiovascular risk factor in women. Rev Obstet Gynecol. 2009;2:232–239.
   PubMedGoogle Scholar
• Teede H, Deeks A, Moran L. Polycystic ovary syndrome: A complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010;8:41.
   PubMed Web of Science ®Google Scholar
• Sverrisdóttir YB, Mogren T, Kataoka J, Janson PO, Stener-Victorin E. Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth? Am J Physiol Endocrinol Metab. 2008;294:E576–E581.
   PubMed Web of Science ®Google Scholar
• Masuo K, Mikami H, Ogihara T, Tuck ML. Sympathetic nerve hyperactivity precedes hyperinsulinemia and blood pressure elevation in a young, nonobese Japanese population. Am J Hypertens. 1997;10:77–83.
   PubMed Web of Science ®Google Scholar
• Mancia G, Bousquet P, Elghozi JL, Esler M, Grassi G, Julius S, . The sympathetic nervous system and the metabolic syndrome. J Hypertens. 2007;25:909–920.
   PubMed Web of Science ®Google Scholar
• Lara HE, Ferruz JL, Luza S, Bustamante DA, Borges Y, Ojeda SR. Activation of ovarian sympathetic nerves in polycystic ovary syndrome. Endocrinology. 1993;133:2690–2695.
   PubMed Web of Science ®Google Scholar
• Barria A, Leyton V, Ojeda SR, Lara HE. Ovarian steroidal response to gonadotropins and beta-adrenergic stimulation is enhanced in polycystic ovary syndrome: Role of sympathetic innervation. Endocrinology. 1993;133:2696–2703.
   PubMed Web of Science ®Google Scholar
• Schlaich MP, Straznickya N, Grimaa M, Ika-Saria C, Dawooda T, Mahfoudb F, . Renal denervation: A potential new treatment modality for polycystic ovary syndrome? J Hypertens. 2011;29:991–996.
   PubMed Web of Science ®Google Scholar
• Mahfoud F, Schlaich M, Kindermann I, Ukena C, Cremers B, Brandt MC, . Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: A pilot study. Circulation. 2011;123: 1940–1946.
   PubMed Web of Science ®Google Scholar
• Esler M. The. 2009 Carl Ludwig Lecture: Pathophysiology of the human sympathetic nervous system in cardiovascular diseases: The transition from mechanisms to medical management. J Appl Physiol. 2010;108:227–237.
   PubMed Web of Science ®Google Scholar
• Krum H, Sobotka P, Mahfoud F, Böhm M, Esler M, Schlaich M. Device-based antihypertensive therapy: Therapeutic modulation of the autonomic nervous system. Circulation. 2011; 123:209–215.
   PubMed Web of Science ®Google Scholar
• Sobotka PA, Mahfoud F, Schlaich MP, Hoppe UC, Böhm M, Krum H. Sympatho-renal axis in chronic disease. Clin Res Cardiol. 2011; Published online June 19. DOI: 10.1007/s00392-011-0335-y
   Google Scholar